NCT00970502 2017-04-10
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
Icahn School of Medicine at Mount Sinai
Phase 1/2 Completed
Icahn School of Medicine at Mount Sinai
UConn Health
University of Alabama at Birmingham
M.D. Anderson Cancer Center